Systematic review and meta-analysis by He et al. [48] identified Beclin-1 as a favorable prognostic marker in gastric cancer, breast cancer, lung cancer, and lymphoma, whereas in colorectal cancer the results were split between favorable and poor prognostic values. This evidence concerns the gene BECN1 and gastric cancer.